Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Long-Term Debt Repayments (2021)

Maxcyte (MXCT) has disclosed Long-Term Debt Repayments for 1 consecutive years, with $4.9 million as the latest value for Q1 2021.

  • Quarterly Long-Term Debt Repayments changed N/A to $4.9 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2021, changed N/A year-over-year, with the annual reading at $4.9 million for FY2021, 241.83% up from the prior year.
  • Long-Term Debt Repayments for Q1 2021 was $4.9 million at Maxcyte.
  • The five-year high for Long-Term Debt Repayments was $4.9 million in Q1 2021, with the low at $4.9 million in Q1 2021.